XML 54 R39.htm IDEA: XBRL DOCUMENT v3.8.0.1
INTANGIBLE ASSETS (Details Narrative)
12 Months Ended
Dec. 31, 2017
USD ($)
Number
Dec. 31, 2016
USD ($)
Dec. 31, 2015
USD ($)
Finite-Lived Intangible Assets [Line Items]      
Amortization expense | $ $ 71,516 $ 54,545 $ 32,441
Number of issued patents 18    
Approved Hormone Therapy Drug Candidate Patents [Member]      
Finite-Lived Intangible Assets [Line Items]      
Useful Life 20 years    
Domestic Utility Patents [Member]      
Finite-Lived Intangible Assets [Line Items]      
Number of issued patents 13    
Foreign Utility Patents [Member]      
Finite-Lived Intangible Assets [Line Items]      
Number of issued patents 3    
Utility Patent Domestic TX-004HR [Member]      
Finite-Lived Intangible Assets [Line Items]      
Number of issued patents 3    
Utility Patent Foreign TX-004HR [Member]      
Finite-Lived Intangible Assets [Line Items]      
Number of issued patents 10    
Utility Patent Pipeline Transdermal Patch Technology [Member]      
Finite-Lived Intangible Assets [Line Items]      
Number of issued patents 1    
Opera Software Patent [Member]      
Finite-Lived Intangible Assets [Line Items]      
Number of issued patents 1